EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism

Qike Fu, Jiaxin Li, Xiufen Gu, Yating Zhang, Pengxun Han, Xuewen Yu, Mumin Shao, Huili Sun, Yuchun Cai iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0348214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Qike Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Shenzhen, Guangdong, C…. Hauptthemen laut MEDLINE: Artemether, Diabetes Mellitus, Type 1, Liver, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Project, Sanming Project of Medicine in Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes mellitus (T1DM) is characterized by autoimmune-mediated destruction of pancreatic islet β-cells and the resultant absolute insulin deficiency, which leads to systemic metabolic dysregulation. Hepatic injury has emerged as a clinically significant complication of T1DM; however, no targeted therapeutic intervention is currently available. Artemether (Art), a methyl ether derivative of artemisinin, has shown potential in ameliorating hyperglycemia, but its efficacy in mitigating T1DM-associated hepatic dysfunction remains insufficiently elucidated. This study comprehensively evaluates the hepatoprotective effects of Art in a murine model of T1DM, with particular emphasis on mitochondrial structural integrity and the regulation of glucose and lipid metabolism. Hepatic function was assessed through histopathological evaluation, ultrastructural examination of mitochondria via transmission electron microscopy, and molecular analysis of gene and protein expression levels. Metabolic intermediates associated with glucose and lipid metabolic pathways were quantitatively analyzed using ultra-high-performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UPLC-QQQ-MS/MS). Administration of Art significantly attenuated both diabetic manifestations and liver injury. Importantly, Art preserved mitochondrial morphology, restored the expression of some proteins related to the respiratory chain complex, and downregulated indicators of hepatic fatty acid β-oxidation, upregulated markers of de novo fatty acid synthesis, normalized intrahepatic triglyceride concentrations, and reduced expression of key molecules involved in gluconeogenesis and glycogenolysis. These findings indicate that Art confers protective effects against liver injury in T1DM through coordinated modulation of mitochondrial function and key metabolic pathways at transcriptional, translational, and metabolic intermediate levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemetherDiabetes Mellitus, Type 1LiverMitochondriaCarbonDiabetes Mellitus, ExperimentalMitochondria, LiverAnimalsMiceMaleLipid MetabolismGlucose

Substanzen

ArtemetherCarbonGlucose

Autor:innen und Institutionen

  • Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Department of Pathology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.

ORCID-Profile: Yuchun Cai

Förderung

  • Shenzhen Science and Technology Project
  • Sanming Project of Medicine in Shenzhen

Zitieren

APA

Fu, Q., Li, J., Gu, X., Zhang, Y., Han, P., Yu, X., Shao, M., Sun, H., & Cai, Y. (2026). Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism. PLOS One. https://doi.org/10.1371/journal.pone.0348214

Vancouver

Fu Q, Li J, Gu X, Zhang Y, Han P, Yu X, et al. Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism. PLOS One. 2026. doi:10.1371/journal.pone.0348214

BibTeX
@article{Fu2026,
  author = {Fu, Qike and Li, Jiaxin and Gu, Xiufen and Zhang, Yating and Han, Pengxun and Yu, Xuewen and Shao, Mumin and Sun, Huili and Cai, Yuchun},
  title = {Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0348214}
}
Kostenlos starten →